[Lithium and glycoregulation disorders].
D000818:Animals; D001714:Bipolar Disorder / Q000188:drug therapy*; D050260:Carbohydrate Metabolism; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007408:Intestinal Absorption / Q000187:drug effects; D008094:Lithium / Q000009:adverse effects* / Q000627:therapeutic use; D008112:Liver Glycogen / Q000378:metabolism; D051381:Rats; D011972:Receptor, Insulin / Q000187:drug effects
D007328:Insulin; D008112:Liver Glycogen; D008094:Lithium; D011972:Receptor, Insulin
Lithium et troubles de la glycorégulation.